This is a non-core endpoint: only basic statistics are computed.
Melanoma in situ of scalp and neck
CD2_INSITU_MELANOMA_SCALPNECK_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D03
- Name in latin
- Melanoma in situ verticis cranii
Similar endpoints
↥List of similar endpoints to
Melanoma in situ of scalp and neck
based on the number of shared cases.
Similar with more cases:
- Melanoma in situ of scalp and neck
- Melanoma in situ
- Melanoma in situ
- Malignant melanoma
- Malignant melanoma, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 76 | 25 | 51 |
| Unadjusted period prevalence (%) | 0.02 | 0.01 | 0.02 |
| Median age at first event (years) | 70.48 | 71.86 | 69.80 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 70
- Matched controls
- 700
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D03.4
ICD-10 Finland
Melanoma in situ of scalp and neck
+∞
100.5
70
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
322.7
62.8
57
9
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
16.8
17.4
29
28
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
32.5
16.3
21
9
L57.0
ICD-10 Finland
Actinic keratosis
12.3
15.4
30
40
8720/2-C44.9
ICD-O-3
Melanoma in situ of skin, NOS
+∞
12.9
12
*
R23.8
ICD-10 Finland
Other and unspecified skin changes
8.8
12.3
29
52
D22.4
ICD-10 Finland
Melanocytic naevi of scalp and neck
78.4
12.0
13
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
+∞
11.8
11
*
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
18.1
11.8
18
13
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
28.5
10.7
14
6
D03.31
ICD-10 Finland
Melanoma in situ in another or unspecified part of the face
+∞
9.6
9
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
101.7
8.6
9
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
+∞
8.5
8
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
8.5
8
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
8.5
8
*
ZZR00
NOMESCO Finland
Flap of skin
28.7
7.8
10
*
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
15.7
7.7
12
9
S18
ICPC
Laceration/cut
4.2
7.4
48
237
8742/2-C44.9
ICD-O-3
Lentigo maligna of skin, NOS
+∞
7.4
7
*
130
Kela drug reimbursment
Malignant tumour
+∞
7.4
7
*
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
22.9
7.4
10
5
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
19.1
7.0
10
6
D22.3
ICD-10 Finland
Melanocytic naevi of other and unspecified parts of face
29.6
6.4
8
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
6.3
6
*
C43.42
ICD-10 Finland
Malignant melanoma of the scalp and neck: 'superficial spreading' type
+∞
6.3
6
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
6.3
6
*
WF002
NOMESCO Finland
Radical radiotherapy
+∞
6.3
6
*
116
Kela drug reimbursment
Prostate cancer
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3002256) Pathology report gross observation
44
35
28.48
49.72
1.9
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
60
153
14.88
27.81
4.3
1.5
—
—
—
0
0
(4035726)
16
12
16.62
17.34
1.4
1.2
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
40
188
3.38
6.40
9.0
4.5
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
50
271
3.47
6.30
6.2
3.5
g/l
35.2
34.7
0.31
43
249
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
0
+∞
5.26
1.0
0.0
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
5
0
+∞
5.26
1.0
0.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
0
+∞
5.26
1.0
0.0
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
12
30
4.56
4.63
5.3
1.4
ug/l
4.5
2.6
0.47
12
22
(3037522) Nuclear Ab [Titer] in Serum
19
68
3.39
4.52
1.6
1.3
titre
573.3
723.6
—
6
22
(3002582) Erythrocytes [#/volume] in Urine
37
195
2.75
4.46
4.1
3.2
e6/l
99.9
55.9
0.37
28
149
(3018095) Leukocytes [#/volume] in Urine
41
228
2.73
4.44
4.9
3.6
e6/l
305.2
115.7
0.52
29
166
(3013115) Eosinophils [#/volume] in Blood
49
301
2.77
4.32
9.3
4.7
e9/l
0.2
0.2
1.16
41
259
(3001604) Monocytes [#/volume] in Blood
47
287
2.67
4.13
9.0
4.8
e9/l
0.7
0.6
0.38
37
236
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
24
106
2.85
3.98
3.5
3.1
e6/l
1.3
3.1
0.72
15
60
(3006315) Basophils [#/volume] in Blood
47
291
2.61
3.96
9.0
4.7
e9/l
0.0
0.0
0.37
38
243
(36304419) Bacteria [Presence] in Urine
33
173
2.60
3.92
3.8
2.7
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
47
293
2.58
3.87
9.2
4.8
e9/l
1.8
1.9
0.24
39
249
(3015377) Calcium [Moles/volume] in Serum or Plasma
36
198
2.55
3.86
4.9
2.2
mmol/l
2.4
2.3
0.63
30
163
(3013650) Neutrophils [#/volume] in Blood by Automated count
51
331
2.64
3.86
12.6
5.4
e9/l
4.4
4.6
0.38
39
283
(40768443) Skin Pathology biopsy report
9
17
5.85
3.63
1.0
1.1
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
46
291
2.47
3.57
8.7
5.9
mmol/l
1.2
1.2
0.62
41
254
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
64
481
3.09
3.37
9.5
4.9
u/l
77.0
79.3
0.21
58
435
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
7
11
6.88
3.26
2.4
2.0
g/l
3.5
5.2
—
7
11
(3005719) IgG [Mass/volume] in Serum or Plasma
12
39
3.47
3.25
2.8
2.1
g/l
10.7
10.5
0.05
12
31
(3021589) Normoblasts [#/volume] in Blood
41
257
2.29
3.12
12.8
8.5
e9/l
0.0
0.0
0.00
29
204
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
7
12
6.30
3.09
1.4
1.2
%
75.3
84.8
—
7
12
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
47
314
2.30
3.05
10.5
6.2
mmol/l
1.2
1.2
0.28
38
269
(3030467) Casts [#/volume] in Urine by Automated count
32
182
2.31
3.05
4.0
2.9
e6/l
0.1
0.4
1.43
23
136
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
23
113
2.48
3.02
3.2
2.8
e6/l
0.4
0.9
1.24
14
66
(3036489) Thrombin time
8
17
5.12
3.01
1.5
1.3
s
23.3
19.6
—
8
17
(3007164) IgA [Mass/volume] in Serum or Plasma
20
92
2.59
3.00
1.9
1.3
g/l
2.4
3.1
0.86
14
46
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
37
227
2.23
2.92
4.6
3.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
31
179
2.24
2.81
4.3
2.6
ug/l
0.7
0.8
0.28
21
126
(40760888) Immunoglobulin light chains.free panel - Serum
6
10
6.40
2.75
12.2
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
66
525
2.95
2.73
22.2
15.3
%
41.1
39.9
0.72
40
319
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
25
134
2.29
2.68
2.6
2.0
—
—
—
0
0
(3018418) pH of Serum or Plasma
31
183
2.17
2.63
5.2
3.6
ph
7.4
7.4
—
5
32
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
60
460
2.45
2.62
3.3
4.0
pmol/l
15.4
15.2
0.18
50
399
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
70
594
3.26
2.57
22.0
13.6
ml/min/173m2
72.0
72.4
0.05
60
468
(3004588) Protein electrophoresis panel - Serum or Plasma
12
46
2.91
2.50
4.6
1.3
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
7
17
4.42
2.42
1.3
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
28
165
2.10
2.35
1.9
1.7
mmol/l
1.6
1.3
0.65
21
128
(3021879) Hepatitis B virus core Ab [Presence] in Serum
8
24
3.60
2.25
1.0
1.4
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
14
62
2.54
2.24
5.6
6.5
mmol/l
8.4
11.7
1.12
14
57
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
11
43
2.82
2.21
1.1
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
7
19
3.95
2.21
1.6
5.8
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
19
98
2.25
2.19
2.8
1.9
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
11
44
2.75
2.12
1.2
1.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
55
424
2.08
2.11
5.2
4.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
5
10
5.26
2.10
1.0
1.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
5
10
5.26
2.10
1.0
1.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
12
51
2.61
2.07
1.1
1.4
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
9
33
2.95
2.01
3.3
1.2
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
57
453
2.03
1.91
4.9
4.1
mm/h
14.4
12.8
0.29
52
403
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
11
47
2.57
1.88
1.1
1.9
%
1.4
2.0
—
6
32
(40768797) Stomach Pathology biopsy report
17
90
2.15
1.83
1.5
1.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
39
277
1.84
1.81
9.3
11.1
inr
1.2
1.5
—
9
71
(3000494) Fungus identified in Specimen by Culture
16
83
2.18
1.81
1.4
1.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
39
279
1.82
1.76
2.0
2.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
5
13
4.04
1.74
1.2
1.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
28
181
1.87
1.74
2.7
2.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
5
14
3.74
1.64
3.6
1.9
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
11
51
2.35
1.59
1.9
2.1
u/l
26.2
36.0
1.52
11
40
(3000492) Spirometry study
11
51
2.35
1.59
1.8
1.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
35
248
1.76
1.59
3.8
3.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
14
73
2.13
1.56
2.8
1.8
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
15
3.49
1.55
1.0
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
9
37
2.62
1.54
2.8
1.8
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
11
52
2.30
1.53
2.8
1.5
nmol/l
370.5
402.5
0.15
11
47
(3009445) Proteinase 3 Ab [Units/volume] in Serum
7
29
2.55
1.43
1.0
1.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
34
245
1.70
1.42
2.4
2.2
nmol/l
83.5
78.3
0.41
29
206
(40758558) Short blood count panel - Blood
22
140
1.80
1.41
10.3
4.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
5
17
3.07
1.38
1.4
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
5
17
3.07
1.38
3.0
3.9
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
10
48
2.25
1.34
3.7
3.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
27
185
1.71
1.34
5.2
4.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
70
631
2.38
1.32
5.8
5.0
mmol/l
4.4
4.3
0.30
61
575
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
5
18
2.90
1.30
1.4
1.7
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
8
37
2.30
1.26
1.1
1.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
39
299
1.63
1.25
5.2
5.2
estimate
0.0
0.0
—
8
45
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
13
72
1.97
1.24
2.8
1.9
—
—
—
0
0
(3013512) EKG study
30
217
1.63
1.20
5.6
4.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
68
611
2.07
1.20
4.9
4.5
mmol/l
1.4
1.3
0.67
57
548
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
66
584
1.99
1.20
5.1
4.7
mu/l
2.2
2.0
0.20
55
512
(3049717) Cytology report of Urine Cyto stain
5
20
2.60
1.17
1.6
1.6
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
69
627
2.09
1.12
6.0
4.9
mmol/l
1.4
1.4
0.05
58
568
(3012544) pH of Venous blood
13
75
1.88
1.11
2.7
3.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
32
240
1.58
1.09
4.5
3.3
mmol/l
8.0
7.9
0.03
24
190
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
68
616
1.99
1.07
7.7
7.1
mmol/mol
41.4
41.4
0.01
58
572
(3009261) Glucose [Presence] in Urine by Test strip
39
307
1.56
1.07
4.4
4.0
estimate
0.0
0.0
—
8
40
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
15
95
1.72
0.96
5.5
5.0
%
33.1
32.6
—
9
62
(3019225) pH of Specimen
11
64
1.84
0.92
9.4
3.5
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
25
185
1.52
0.87
3.6
3.3
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
37
299
1.46
0.84
4.5
3.9
estimate
0.0
0.0
—
8
45
(3042936) Bacteria identified in Isolate by Culture
15
99
1.64
0.83
1.2
1.7
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
34
272
1.45
0.81
5.6
3.7
%
19.7
25.6
1.77
20
142
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
5
23
2.25
0.77
1.0
1.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
22
163
1.49
0.76
5.0
4.4
estimate
0.0
0.0
—
8
43
(36660697) Celiac disease serology panel - Serum
7
39
1.87
0.75
1.0
1.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
9
57
1.66
0.74
11.9
9.8
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
5
25
2.07
0.74
2.8
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
16
111
1.56
0.73
5.6
3.9
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
30
240
1.41
0.69
5.1
3.3
mg/l
49.4
72.0
0.44
24
156
(4010399)
7
44
1.65
0.67
1.3
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
0
21
0.00
0.61
0.0
4.4
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
0
22
0.00
0.60
0.0
1.8
—
6.7
—
0
8
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
6
36
1.72
0.58
1.3
2.6
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
42
364
1.34
0.57
6.9
3.8
ug/l
2.4
2.0
0.46
33
317
(3022145) Colonoscopy Study observation
9
60
1.57
0.57
1.8
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
21
164
1.39
0.54
3.8
3.6
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
31
259
1.33
0.53
5.6
4.2
mg/mmol
10.3
9.2
0.10
21
167
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
6
40
1.54
0.53
2.7
2.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
7
46
1.57
0.50
1.6
1.7
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
8
56
1.48
0.44
2.0
2.1
g/l
0.3
0.2
—
8
46
(3018677) aPTT in Platelet poor plasma by Coagulation assay
16
124
1.37
0.43
3.1
1.5
s
31.2
29.9
0.24
16
118
(3022948) Iron [Moles/volume] in Serum or Plasma
15
115
1.38
0.43
2.0
2.4
umol/l
16.2
12.4
1.47
15
105
(3014051) Protein [Presence] in Urine by Test strip
0
15
0.00
0.41
0.0
2.7
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
12
89
1.41
0.41
5.8
8.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
9
66
1.41
0.40
2.1
3.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
67
637
1.44
0.39
18.6
13.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
18
145
1.32
0.38
4.6
3.8
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
35
308
1.25
0.38
2.6
2.0
pmol/l
83.8
95.7
0.68
20
156
(3015736) pH of Urine
27
232
1.25
0.35
4.3
3.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
27
234
1.24
0.33
4.6
4.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
17
139
1.29
0.32
1.2
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
7
52
1.38
0.32
2.4
4.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
13
103
1.32
0.30
1.8
2.3
%
27.5
21.4
1.07
13
93
(40761535) Cells panel - Urine sediment
8
62
1.32
0.29
3.1
3.2
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
13
105
1.29
0.27
1.9
2.4
g/l
2.2
2.2
0.06
13
97
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
18
152
1.24
0.27
1.3
1.8
pmol/l
342.1
421.7
1.42
13
118
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
5
41
1.23
0.22
20.2
9.1
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
0
11
0.00
0.21
0.0
1.8
—
1.7
—
0
11
(3024891) Influenza virus A+B Ag [Presence] in Specimen
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(4094501)
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
0
14
0.00
0.20
0.0
2.9
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
27
292
0.88
0.15
4.7
4.2
ng/l
40.9
56.5
0.46
20
225
(1761868) Lipid panel - Serum or Plasma
21
191
1.14
0.13
4.1
3.6
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
7
80
0.86
0.07
1.6
1.9
—
—
—
0
0
(3044889) 12 lead EKG panel
48
471
1.05
0.03
5.5
4.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
7
0.00
0.00
0.0
2.9
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
0
7
0.00
0.00
0.0
2.9
—
107.4
—
0
7
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(44806420)
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
0
7
0.00
0.00
0.0
2.9
—
4.2
—
0
7
(3026389) Candida sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
6
0.00
0.00
0.0
1.0
—
2.7
—
0
6
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.0
—
19.2
—
0
6
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
75.9
—
0
6
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
6.5
—
0
5
(1175426) CD3 cells/100 lymphocytes in Blood
0
5
0.00
0.00
0.0
1.2
—
69.4
—
0
5
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
6
61
0.98
0.00
7.5
3.1
kpa
4.6
4.9
—
6
56
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
0.2
—
0
5
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
506.0
—
0
5
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(4306422)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
1.7
—
0
5
(3048689) Calprotectin [Mass/mass] in Stool
5
54
0.92
0.00
2.8
1.9
ug/g
116.4
145.4
—
5
41
(3022806) Fractional oxyhemoglobin in Capillary blood
0
8
0.00
0.00
0.0
1.6
—
87.3
—
0
8
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
6
68
0.87
0.00
2.0
1.6
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_MELANOMA_SCALPNECK_EXALLC – Melanoma in situ of scalp and neck
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).